Literature DB >> 28374281

Prevention of Sexually Transmitted Diseases in HIV-Infected Individuals.

Laura Quilter1, Shireesha Dhanireddy2, Jeanne Marrazzo3.   

Abstract

Prevention of sexually transmitted infections (STIs) is an important part of the care of the HIV-infected individual. STIs have been associated with increased risk of transmission and acquisition of HIV. Among HIV-infected persons, treatment failures and high recurrence rates of some STIs are more common. Despite the recognized importance of prevention and discussion of sexual health, rates of screening for STIs are suboptimal. Moreover, rates of STIs such as syphilis continue to increase particularly in men who have sex with men (MSM). This review focuses on the most common STIs seen among HIV-infected individuals and recommendations for screening and prevention.

Entities:  

Keywords:  Chlamydia; Gonorrhea; HIV; Hepatitis C; Sexually transmitted diseases; Syphilis

Mesh：

Year:  2017        PMID： 28374281     DOI： 10.1007/s11904-017-0350-3

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN： 1548-3568            Impact factor:   5.071


  42 in total

1.  Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management.

Authors:  Ina U Park; Joan M Chow; Gail Bolan; Mark Stanley; Jennifer Shieh; Jeffrey M Schapiro
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

2.  Hepatitis C in the United States.

Authors:  Scott D Holmberg; Philip R Spradling; Anne C Moorman; Maxine M Denniston
Journal:  N Engl J Med       Date:  2013-05-16       Impact factor: 91.245

3.  HIV incidence among men with and those without sexually transmitted rectal infections: estimates from matching against an HIV case registry.

Authors:  Preeti Pathela; Sarah L Braunstein; Susan Blank; Julia A Schillinger
Journal:  Clin Infect Dis       Date:  2013-06-25       Impact factor: 9.079

4.  Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada.

Authors:  Vanessa G Allen; Leo Mitterni; Christine Seah; Anuradha Rebbapragada; Irene E Martin; Colin Lee; Heather Siebert; Lynn Towns; Roberto G Melano; Donald E Low
Journal:  JAMA       Date:  2013-01-09       Impact factor: 56.272

5.  Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.

Authors:  Jairam R Lingappa; Jared M Baeten; Anna Wald; James P Hughes; Katherine K Thomas; Andrew Mujugira; Nelly Mugo; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; James Kiarie; Carey Farquhar; Grace John Stewart; Joseph Makhema; Myron Essex; Edwin Were; Kenneth H Fife; Guy de Bruyn; Glenda E Gray; James A McIntyre; Rachel Manongi; Saidi Kapiga; David Coetzee; Susan Allen; Mubiana Inambao; Kayitesi Kayitenkore; Etienne Karita; William Kanweka; Sinead Delany; Helen Rees; Bellington Vwalika; Amalia S Magaret; Richard S Wang; Lara Kidoguchi; Linda Barnes; Renee Ridzon; Lawrence Corey; Connie Celum
Journal:  Lancet       Date:  2010-02-12       Impact factor: 79.321

6.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

Review 7.  Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention.

Authors:  Seth C Kalichman; Jennifer Pellowski; Christina Turner
Journal:  Sex Transm Infect       Date:  2011-02-17       Impact factor: 3.519

8.  Surveillance for acute viral hepatitis--United States, 2006.

Authors:  Annemarie Wasley; Scott Grytdal; Kathleen Gallagher
Journal:  MMWR Surveill Summ       Date:  2008-03-21

9.  HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe.

Authors:  Patrick Ingiliz; Thomas C Martin; Alison Rodger; Hans-Jürgen Stellbrink; Stefan Mauss; Christoph Boesecke; Mattias Mandorfer; Julie Bottero; Axel Baumgarten; Sanjay Bhagani; Karine Lacombe; Mark Nelson; Jürgen K Rockstroh
Journal:  J Hepatol       Date:  2016-09-17       Impact factor: 25.083

10.  Primary and secondary syphilis--United States, 2005-2013.

Authors:  Monica E Patton; John R Su; Robert Nelson; Hillard Weinstock
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-05-09       Impact factor: 17.586
View more
  3 in total

1.  Lifetime prevalence of syphilis infection among predominantly Black sexual and gender minorities living with HIV in Atlanta, Georgia: a cross-sectional analysis.

Authors:  John Mark Wiginton; Lisa A Eaton; Jolaade Kalinowski; Ryan J Watson; Seth C Kalichman
Journal:  Ethn Health       Date:  2021-11-24       Impact factor: 2.732

2.  Improving sexually transmitted infection screening, testing, and treatment among people with HIV: A mixed method needs assessment to inform a multi-site, multi-level intervention and evaluation plan.

Authors:  Kathleen Cullinen; Macsu Hill; Taylor Anderson; Veronica Jones; John Nelson; Mirna Halawani; Peijia Zha
Journal:  PLoS One       Date:  2021-12-28       Impact factor: 3.240

3.  Sexually transmitted infections and HIV RNA levels in blood and anogenital compartments among Thai men who have sex with men before and after antiretroviral therapy: implication for Treatment as Prevention programme.

Authors:  Nittaya Phanuphak; Supanit Pattanachaiwit; Tippawan Pankam; Nipat Teeratakulpisarn; Parinya Chamnan; Panita Pathipvanich; Suchart Thongpaen; Siriporn Nonenoy; Jureeporn Jantarapakde; Supabhorn Pengnonyang; Deondara Trachunthong; Thanthip Sungsing; Kittiyaporn Parasate; Sriprai Seeneewong Na Ayutthaya; Ketmookda Trairat; Kanitta Pussadee; Cheewanan Lertpiriyasuwat; Praphan Phanuphak
Journal:  J Int AIDS Soc       Date:  2018-09       Impact factor: 5.396
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.